Works matching IS 2160763X AND DT 2018 AND VI 7 AND IP 5
Results: 12
Systemic Pharmacokinetics, Safety, and Preliminary Efficacy of Topical AhR Agonist Tapinarof: Results of a Phase 1 Study.
- Published in:
- Clinical Pharmacology in Drug Development, 2018, v. 7, n. 5, p. 524, doi. 10.1002/cpdd.439
- By:
- Publication type:
- Article
Pharmacokinetic Evaluation of Two Nicotine Patches in Smokers.
- Published in:
- Clinical Pharmacology in Drug Development, 2018, v. 7, n. 5, p. 506, doi. 10.1002/cpdd.431
- By:
- Publication type:
- Article
Phase 1b Trial of Ficlatuzumab, a Humanized Hepatocyte Growth Factor Inhibitory Monoclonal Antibody, in Combination With Gefitinib in Asian Patients With NSCLC.
- Published in:
- Clinical Pharmacology in Drug Development, 2018, v. 7, n. 5, p. 532, doi. 10.1002/cpdd.427
- By:
- Publication type:
- Article
A Phase 1, Randomized, Placebo‐ and Active‐Controlled Crossover Study to Determine the Effect of Single‐Dose Ertugliflozin on QTc Interval in Healthy Volunteers.
- Published in:
- Clinical Pharmacology in Drug Development, 2018, v. 7, n. 5, p. 513, doi. 10.1002/cpdd.421
- By:
- Publication type:
- Article
To Take or Not to Take With Meals? Unraveling Issues Related to Food Effects Labeling for Oral Antineoplastic Drugs.
- Published in:
- Clinical Pharmacology in Drug Development, 2018, v. 7, n. 5, p. 455, doi. 10.1002/cpdd.416
- By:
- Publication type:
- Article
Single‐Dose Bioequivalence of Two Mini Nicotine Lozenge Formulations.
- Published in:
- Clinical Pharmacology in Drug Development, 2018, v. 7, n. 5, p. 498, doi. 10.1002/cpdd.415
- By:
- Publication type:
- Article
Pharmacokinetics, Pharmacodynamics, and Safety of a Long‐Acting Human Growth Hormone (MOD‐4023) in Healthy Japanese and Caucasian Adults.
- Published in:
- Clinical Pharmacology in Drug Development, 2018, v. 7, n. 5, p. 554, doi. 10.1002/cpdd.414
- By:
- Publication type:
- Article
Two Phase 1, Open‐Label, Single‐Dose, Randomized, Crossover Studies to Assess the Pharmacokinetics, Safety, and Tolerability of Orally Administered Granules of Secnidazole (2 g) in Healthy Female Volunteers Under Different Administration Conditions
- Published in:
- Clinical Pharmacology in Drug Development, 2018, v. 7, n. 5, p. 543, doi. 10.1002/cpdd.406
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- Clinical Pharmacology in Drug Development, 2018, v. 7, n. 5, p. 451, doi. 10.1002/cpdd.402
- Publication type:
- Article
Phase 1, Randomized, Double‐Blind, Placebo‐Controlled Studies on the Safety, Tolerability, and Pharmacokinetics of Naldemedine in Healthy Volunteers.
- Published in:
- Clinical Pharmacology in Drug Development, 2018, v. 7, n. 5, p. 474, doi. 10.1002/cpdd.387
- By:
- Publication type:
- Article
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Domagrozumab (PF‐06252616), an Antimyostatin Monoclonal Antibody, in Healthy Subjects.
- Published in:
- Clinical Pharmacology in Drug Development, 2018, v. 7, n. 5, p. 484, doi. 10.1002/cpdd.386
- By:
- Publication type:
- Article
Population Pharmacokinetics of Lenalidomide in Healthy Volunteers and Patients With Hematologic Malignancies.
- Published in:
- Clinical Pharmacology in Drug Development, 2018, v. 7, n. 5, p. 465, doi. 10.1002/cpdd.372
- By:
- Publication type:
- Article